FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling

BACKGROUND: The resistance to EGF receptor (EGFR) tyrosine kinase inhibitors (TKI) is a major challenge in the treatment of non-small cell lung cancer (NSCLC). Understanding the molecular mechanisms behind resistance is therefore an important issue. Here we assessed the role of EGFR pathway substrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Qiang, Jiao, Xinwei, Kuang, Fei, Hou, Beibei, Zhu, Yajing, Guo, Wenyu, Sun, Guangxin, Ba, Yufeng, Yu, Dandan, Wang, David, Zhang, Faya, Qiao, Hui Chao, Wang, Shuolin, Tang, Shu, Qiao, Hailing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413682/
https://www.ncbi.nlm.nih.gov/pubmed/30738830
http://dx.doi.org/10.1016/j.ebiom.2019.01.053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413682/
https://www.ncbi.nlm.nih.gov/pubmed/30738830
http://dx.doi.org/10.1016/j.ebiom.2019.01.053

Ejemplares similares